Sickle Cell made Simple and Rapid.
The layman says, know your genotype; but professionally know your haemoglobin variants or types. Instantly. Accurately. Anywhere.
Sickle Cell Disease remains subtle but devastating in many regions, often undiagnosed until complications arise. Traditional electrophoresis and laboratory methods, while accurate, are costly, time-consuming, and inaccessible in most community settings. For newborns and at-risk adults alike, every delay in diagnosis increases preventable morbidity and missed opportunities for early intervention.
Current Screening Challenges
- Complex Lab Tests: Require skilled personnel and specialised equipment
- Delayed Results: Turnaround times can exceed days to weeks
- Limited Reach: Inaccessible to remote or low-resource clinics
- High Costs: Reagents, cold storage, and electricity add to the burden
In the absence of an easy, rapid, and affordable point-of-care solution, early detection remains beyond the reach of many who need it most.
Introducing MERISCREEN Sickle Cell – Rapid, Reliable, Revolutionary.
Comprehensive Genotype Detection – Accurately differentiates HbA, HbS, and HbC traits in a single test
Rapid Results in 15 Minutes – Enables same-visit diagnosis and counseling
High Sensitivity and Specificity – Comparable to standard electrophoresis methods
No Equipment Needed – Works with a simple finger-prick blood sample.
Ideal for Field and Outreach Settings – Stable at ambient temperature, no cold chain required.
Empowering Public Health Programs – Perfect for neonatal, school, and community screening initiatives.
With MERISCREEN, healthcare workers can bring reliable sickle cell screening to every doorstep — no lab, no delay, no compromise. Early diagnosis leads to informed counselling, better management and healthier communities.
Fast. Accurate. Accessible.
Explore Sickle Cell Screening with MERISCREEN
👉 For More Enquiries Contact Us via email sa***@*****bx.com| Phone: 07081072395 |07045551222